An Aug. 9 article incorrectly said that the cholesterol-lowering drug cerivastatin (Baycol) had a 2.5 percent share of the market for statin drugs at the end of 2000. That was its market share at ...

Bayer's voluntary withdrawal of cerivastatin from the U.S. market led to questions regarding the safety of all hydroxymethylglutaryl–coenzyme A reductase inhibitors, or statins. Myopathy and the ...

The lack of a pharmacokinetic interaction between cerivastatin and orlistat could be demonstrated according to current guidelines. [11] This confirms that the pharmacokinetic profile of ...

Twelve Caucasian males, aged between 20 and 49 years, weighing between 59 and 107kg, received single oral doses of cerivastatin sodium 0.8mg (Bayer AG, Leverkusen, Germany) alone or on the seventh ...